Cargando…
Anti-Proliferative Activity of Glucagon-Like Peptide-1 Receptor Agonist on Obesity-Associated Breast Cancer: The Impact on Modulating Adipokines’ Expression in Adipocytes and Cancer Cells
Obesity is associated with high risk and poor prognosis of breast cancer (BC). Obesity promotes BC cells proliferation via modulating the production of adipokines, including adiponectin (anti-neoplastic adipokine), leptin (carcinogenic adipokine) and inflammatory mediators. In the present study we i...
Autores principales: | Alanteet, Alaa A., Attia, Hala A., Shaheen, Sameerah, Alfayez, Musaed, Alshanawani, Bisher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903831/ https://www.ncbi.nlm.nih.gov/pubmed/33746653 http://dx.doi.org/10.1177/1559325821995651 |
Ejemplares similares
-
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
por: Geloneze, Bruno, et al.
Publicado: (2017) -
Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective
por: Alkhatib, Nimer S., et al.
Publicado: (2022) -
Adipocyte-Derived Adipokines and Other Obesity-Associated Molecules in Feline Mammary Cancer
por: Marshall, Taylor, et al.
Publicado: (2023) -
Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet
por: Jin, Miaomiao, et al.
Publicado: (2020) -
Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?
por: Lisco, Giuseppe, et al.
Publicado: (2023)